The study of arrhythmias and electrophysiology encompasses cutting-edge research and therapies to address irregularities in cardiac rhythm. From catheter-based ablation techniques to advanced wearable monitoring devices, progress in this field has improved both diagnosis and treatment precision. Conditions like supraventricular tachycardia and long QT syndrome are increasingly understood through sophisticated electrophysiological testing. Additionally, advancements in cryoablation and robotic catheter navigation have minimized procedural risks while enhancing outcomes. Artificial intelligence is also being integrated into electrophysiology to predict arrhythmia episodes and optimize device programming. As the field grows, it holds immense potential to transform arrhythmia care and cardiac health management globally.
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Young hearts at risk: Hidden cardiovascular damage and the role of social determinants of health among youth with type 1 diabetes in Kenya
Phoebe Wamalwa, Ministry of Health, Kenya